Incannex Healthcare Limited
IXHL · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 378.7% | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 100% | 100% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -55,920.9% | -154,200% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -54,517.4% | -153,825% | – | – |
| EPS Diluted | -1.36 | -1.14 | -3.17 | -0.035 |
| % Growth | -19.3% | 64% | -9,061.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |